S
Supernus Pharmaceuticals (SUPN)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Supernus Pharmaceuticals (SUPN)
Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The Company offers Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (exten... Read more
- USD32.20
- USD32.31
- USD31.59
- USD40.28
- -0.20%
- 668M
- 32.97k
- 458.71k
- 1.8B
- 25.53
- 5.70%
- 15.00%
Stock News
2 hours ago
‘It feels like I’m drowning’: I’m crippled by credit-card debt. Should I file for Chapter 13 bankruptcy?
MarketWatch
2 hours ago
Treasury yields soar on hope a recession will be avoided after temporary China-U.S. deal
CNBC
6 hours ago
3 Top REITs To Buy In May 2025
SeekingAlpha
6 hours ago
Duke Energy: I'm Bullish As America Craves More Juice
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
